New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 21, 2014
07:11 EDTILMNIllumina price target raised to $167 from $125 at JMP Securities
After attending Illumina's Analyst Day, JMP Securities believes the company's new initiatives leave it well-positioned to seize opportunities across research and clinical markets. The firm reiterates an Outperform rating on the stock.
News For ILMN From The Last 14 Days
Check below for free stories on ILMN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 9, 2014
08:58 EDTILMNIllumina not targeted by new Chinese regulations, says Janney Capital
Subscribe for More Information
April 7, 2014
07:30 EDTILMNIllumina weakness creates buying opportunity, says Wells Fargo
Wells Fargo believes that the recent decline in Illumina's stock is mostly related to its correlation with biotech indices, and the firm sees this correlation as "a technical rather than a fundamental phenomenon." The firm believes that demand for the company's HiSeq, MiSeq, and HiSeq X instruments are strong, and it now identifies the stock as its top pick in the tools space. It increased its price target on the shares to $170-175 from $155-$160.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use